JPH05500304A - A method of introducing molecules, especially genetic material, into plant cells - Google Patents
A method of introducing molecules, especially genetic material, into plant cellsInfo
- Publication number
- JPH05500304A JPH05500304A JP51026590A JP51026590A JPH05500304A JP H05500304 A JPH05500304 A JP H05500304A JP 51026590 A JP51026590 A JP 51026590A JP 51026590 A JP51026590 A JP 51026590A JP H05500304 A JPH05500304 A JP H05500304A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- plant
- sound wave
- molecules
- plant cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 59
- 102000004169 proteins and genes Human genes 0.000 title claims description 22
- 108090000623 proteins and genes Proteins 0.000 title claims description 22
- 210000004027 cell Anatomy 0.000 claims description 65
- 241000196324 Embryophyta Species 0.000 claims description 54
- 239000013612 plasmid Substances 0.000 claims description 20
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 8
- 235000021536 Sugar beet Nutrition 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 238000009210 therapy by ultrasound Methods 0.000 claims description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 5
- 244000061176 Nicotiana tabacum Species 0.000 claims description 4
- 238000002525 ultrasonication Methods 0.000 claims description 4
- 241000209510 Liliopsida Species 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 210000003463 organelle Anatomy 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 2
- 210000001938 protoplast Anatomy 0.000 description 20
- 210000004102 animal cell Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 8
- 238000000527 sonication Methods 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 230000009466 transformation Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- VVOIFRARHIZCJD-GHMZBOCLSA-N chloramphenicol 3-acetate Chemical compound CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 VVOIFRARHIZCJD-GHMZBOCLSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000001002 morphogenetic effect Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8206—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】 植物細胞に分子、特に遺伝物質を導入する方法技術分野 本発明は無傷植物細胞に分子、特に遺伝物質を導入する方法に関するものである 。[Detailed description of the invention] A method of introducing molecules, especially genetic material, into plant cellsTechnical field The present invention relates to a method for introducing molecules, particularly genetic material, into intact plant cells. .
背景技術 動物細胞およびプロトプラストに、分子、例えばプラスミドDNA、RNA、ウ ィルスまたはこれらの物質の断片のような遺伝物質を導入する方法はいくつか知 られている。Background technology Animal cells and protoplasts are injected with molecules such as plasmid DNA, RNA, There are several known ways to introduce genetic material, such as viruses or fragments of these materials. It is being
このような既知方法としてはなかんずく化学的方法、エレクトロポレーション( electroporation) およびマイクロインジェクションかある。Such known methods include, inter alia, chemical methods, electroporation ( electroporation) and microinjection.
このような既知方法は過渡的および安定的な両方の形質転換(transfor mation)において実施することかできる。一般に、過渡的な発現を達成す る開示されたすべての方法は、安定的な形質転換を達成するのに有用であること か分った。Such known methods are suitable for both transient and stable transformation. It can be implemented in In general, achieving transient expression All disclosed methods are useful for achieving stable transformation. I understand.
遺伝物質の導入に関し、植物プロトプラストおよび動物細胞は両方とも、原形質 膜のみによって周囲から隔離されているという共通の一つの重要な特徴を有する 。他方、無傷植物細胞は原形質膜のほかに高分子化合物か透過てきない細胞壁を 有し、該細胞壁は繊維素フィブリル、ペクチンおよびしばしばリグニンからなる 目のつんだ網状組織である。For the introduction of genetic material, both plant protoplasts and animal cells are have one important characteristic in common: they are isolated from their surroundings only by a membrane . On the other hand, in addition to the plasma membrane, intact plant cells have a cell wall that cannot be penetrated by polymeric compounds. the cell wall is composed of cellulose fibrils, pectin and often lignin It is a blinding network.
植物プロトプラストと動物細胞との間の類似性は、植物プロトプラストに遺伝物 質を導入する既知方法を動物細胞の場合にも使用できるのか普通であるという事 実によって、さらに強調される。The similarity between plant protoplasts and animal cells is that plant protoplasts have genetic material Is it normal to know whether known methods for introducing cells can also be used in animal cells? This is further emphasized by the fruit.
このような方法としては下記の方法かあるニリン酸カルシウムによってプラスミ ドDNAを沈澱させて、結晶質生成物を得る。動物細胞(Graham and van den Eb。For this purpose, the following method is used: The DNA is precipitated to obtain a crystalline product. Animal cells (Graham and van den Eb.
rVirology、 52.456〜457.1973 J )および植物プ ロトプラスI□ (Hain等、 rMol、、Gen、 Genet、、 1 99.161〜168. 1985 J )は上述の生成物を吸収することがで きる。rVirology, 52.456-457.1973 J) and plant Rotoplus I□ (Hain et al., rMol, Gen, Genet, 1 99.161-168. 1985 J) is able to absorb the above-mentioned products. Wear.
プロトプラスト(Deshayes等、 rEMBO,4,2731〜2737 . 1985J )または動物細胞(Felgner等、 Proc、 Nat l、 Acad、 Sci、 USA。Protoplasts (Deshayes et al., rEMBO, 4, 2731-2737 .. 1985J) or animal cells (Felgner et al., Proc, Nat. l, Acad, Sci, USA.
84、7413.1987)と融合させ、該融合をポリエチレングリコールによ って生じさせる。84, 7413.1987), and the fusion was made with polyethylene glycol. It causes.
ポリエチレングリコール(PEG)を使用する。この方法では、植物プロトプラ ストおよび遺伝物質にポリエチレングリコール、通常40%のポリエチレングリ コール6000を添加する( Krens等、rNature、 296.72 〜74.1982J ) o同様に、ポリエチレンイミンまたはポリーL−オル ニチンを使用することかできる。Use polyethylene glycol (PEG). In this method, plant protoplasts polyethylene glycol, usually 40% polyethylene glycol Add Cole 6000 (Krens et al., rNature, 296.72 ~74.1982J) oSimilarly, polyethyleneimine or polyL-ol You can use Nitin.
エレクトロポレーションを行う。この場合には、動物細胞または植物プロトプラ ストの懸濁液を、遺伝物質の存在下に、高電界強度の短イ電気パルスに曝す(N euman等、rEMBOJ、、l。Perform electroporation. In this case, animal cells or plant protoplasts A suspension of microorganisms is exposed to short electrical pulses of high field strength in the presence of genetic material (N euman et al., rEMBOJ,,l.
841〜845.1982 J ; Fromm等、rNature、 319 .791〜793゜1986J )。841-845.1982 J; Fromm et al., rNature, 319 .. 791-793°1986J).
ミクロインジェクションを行う。この場合には、超微小マイフロピペラI〜によ り、植物プロトプラスト(Crossway等、rMol。Perform microinjection. In this case, the ultra-fine micropipera I~ and plant protoplasts (Crossway et al., rMol.
Gem、 Genet、、 20.179.1986)または動物細胞(Cap pechi。Gem, Genet, 20.179.1986) or animal cells (Cap pechi.
rcell、 22.479〜488.1980 )に遺伝物質を導入する。rcell, 22.479-488.1980).
国際公開公報節89102464号には、DNA断片による動物細胞の形質転換 を、前記動物細胞に該細胞を傷つけるのに十分であるか該細胞を殺すことのない 超音波処理を施すことによって行うことが開示されている。動物細胞と植物プロ トプラストとの間の上述の類似性のために、この方法も植物プロトプラストにD NA断片を導入するのに使用できるのは明らかであると考えられる筈である。上 述の方法はいずれも無傷植物細胞にプラスミドDNAを導入するのに適していな いから、上述の国際公開公報を読んだ当業者は、この方法はプロトプラストを使 用して実施できるという結論に達すると思われる。しかし、当業者か無傷植物細 胞を透過させるのか困難な上述の方法を使用することを考えることはあり得ない 。従って、植物細胞の壁が一般的にDNAおよび蛋白質のような比較的大形の分 子にとって透過不可能であることは、当業者に広く受け入れられることである。International Publication No. 89102464 describes the transformation of animal cells with DNA fragments. to the animal cell, sufficient to damage the cell or without killing the cell. It is disclosed that this is carried out by applying ultrasonic treatment. animal cell and plant pro Because of the above-mentioned similarities with toplasts, this method also applies to plant protoplasts. It should be obvious that it could be used to introduce NA fragments. Up None of the methods described above are suitable for introducing plasmid DNA into intact plant cells. Therefore, a person skilled in the art who has read the above-mentioned international publication will understand that this method uses protoplasts. It seems that the conclusion can be reached that it can be implemented using However, if a person skilled in the art It is impossible to think of using the above-mentioned method, which is difficult to penetrate the cells. . Therefore, plant cell walls generally contain relatively large molecules such as DNA and proteins. Impermeability to children is widely accepted by those skilled in the art.
従って、この問題を解決するためには、先ず植物細胞の細胞壁を普通酵素加水分 解によって取り除き、次いて生成したプロトプラストに遺伝物質を導入する必要 かあった。しかし、これは普通困難である。それは、全植物をプロトプラストか ら再生することの方か無傷植物細胞から再生することより困難であるのか普通で あるからである。従って、無傷植物細胞に遺伝物質を直接導入してプロトプラス トの生成に関連する問題ならびにプロトプラストからの再生に関連する問題を回 避することかできる方法を見い出すことの必要性は大きい。Therefore, in order to solve this problem, the cell walls of plant cells must first be hydrolyzed with enzymes. the need to remove by solution and then introduce genetic material into the generated protoplasts. There was. However, this is usually difficult. Is all plants protoplasts? Is it usually more difficult to regenerate from intact plant cells than from intact plant cells? Because there is. Therefore, protoplasts can be created by directly introducing genetic material into intact plant cells. issues related to the generation of protoplasts as well as issues related to regeneration from protoplasts. There is a great need to find ways to avoid it.
近年、無傷植物細胞にプラスミドDNAを導入する方法か開発された。この方法 はプラスミドDNAで被覆した小形粒子によって高速で衝撃を加えることに基づ < (Klein等、rNature。Recently, methods have been developed to introduce plasmid DNA into intact plant cells. this method is based on high-velocity bombardment with small particles coated with plasmid DNA. < (Klein et al., rNature.
327、70〜73.1987」)。しかし、この方法は非常に高価な装置を必 要とし、また適正に操作するために相当専門的な知識を必要とする。327, 70-73.1987''). However, this method requires very expensive equipment. and requires considerable specialized knowledge to operate properly.
従って、無傷植物細胞に分子、特に遺伝物質を導入する一層簡単で安価な方法が 必要とされている。Therefore, simpler and cheaper methods of introducing molecules, especially genetic material, into intact plant cells are needed. is necessary.
本発明においては、全く効果的な方法であるか、比較的安価でありかつ容易に入 手できる装置のみを必要とする方法を使用して温和な超音波処理を行うことによ り、無傷植物細胞への分子、特に遺伝物質の導入を達成できることを見い出した 。In the present invention, the method is completely effective, relatively inexpensive and easily accessible. by mild sonication using a method that requires only hand-held equipment. discovered that it is possible to achieve the introduction of molecules, particularly genetic material, into intact plant cells by .
発明の説明 本発明の目的は、安価かつ効果的な方法で、無傷植物細胞に分子、特に遺伝物質 を導入する方法を提供することにある。Description of the invention The object of the invention is to introduce molecules, especially genetic material, into intact plant cells in a cheap and effective manner. The purpose is to provide a method for introducing
本発明の目的は、前記植物細胞および前記分子を含有する培地に温和な超音波処 理を施すことを特徴とする本発明方法によって達成される。It is an object of the present invention to subject the medium containing said plant cells and said molecules to a mild ultrasound treatment. This is achieved by the method of the present invention, which is characterized in that it carries out the following steps.
本発明方法は、従来知られている導入方法とは異なる有用な方法である。本発明 方法は、迅速かつ簡単に実施することかできる低コストの新規な方法を提供する 。既に実施された導入実験に基づいて、本発明方法は、既知方法では不十分であ る多数の他の生体物質に対して使用した場合に、優れた方法であることを、予知 することかできる。The method of the present invention is a useful method different from conventionally known introduction methods. present invention The method provides a novel, low-cost method that is quick and easy to implement. . Based on the introductory experiments already carried out, the method of the present invention has proven that the known methods are insufficient. We predict that this method will be superior when used on a large number of other biological materials. I can do something.
本発明においては、細胞を破壊してホモジネートを生成するかあるいは細胞を溶 解するのに使用される超音波処理より著しく温和な超音波処理を植物細胞に施す 。この超音波処理は適度に温和であるので、十分な数の植物細胞が生きたまま残 る。生存能力を保証するには、植物細胞懸濁液を、5〜300W、好ましくは3 0〜90Wのような600W以下の出力電力(すなわち、電源ユニットの「出力 制御部」から読み取られかつ音波発生手段に供給される出力電力)において、5 kHz 〜10MHz 、特にlO〜100kHzの周波数範囲の超音波に、 100〜30QQms、好ましくは400〜10100Oのような10100O 0以下の期間にわたって曝すのか有利である。In the present invention, cells are disrupted to produce a homogenate, or cells are lysed. subjecting plant cells to ultrasonication, which is significantly milder than the sonication used to . This sonication is reasonably mild so that a sufficient number of plant cells remain alive. Ru. To ensure viability, the plant cell suspension is heated between 5 and 300 W, preferably 3 Output power below 600W, such as 0-90W (i.e., the “output power” of the power supply unit) (output power read from the control unit and supplied to the sound wave generating means), 5 For ultrasonic waves in the frequency range of kHz to 10MHz, especially lO to 100kHz, 10100O such as 100-30QQms, preferably 400-10100O Advantageously, the exposure period is less than or equal to 0.
本発明方法によって植物細胞に導入できる分子の例は、DNA、プラスミドDN A、RNA、ウィルス、蛋白質、脂質、医薬組成物、小形分子、オルガネラまた はこれらの物質の断片である。Examples of molecules that can be introduced into plant cells by the method of the present invention include DNA, plasmid DNA, A, RNA, virus, protein, lipid, pharmaceutical composition, small molecule, organelle or are fragments of these substances.
本発明方法は、テンサイまたはタバコの植物細胞に分子を導入するのに有利に使 用することができる。The method of the invention can be advantageously used to introduce molecules into sugar beet or tobacco plant cells. can be used.
テンサイまたはタバコの植物細胞にプラスミドDNAのような遺伝物質を導入す る場合には、75〜100Wの出力電力において、10〜30kHzの周波数範 囲の超音波を、500〜10100Oの期間にわたって使用することにより、特 に良好な結果が得られる。Introduction of genetic material such as plasmid DNA into sugar beet or tobacco plant cells frequency range from 10 to 30 kHz at an output power of 75 to 100 W. By using ultrasonic waves at a temperature of 500 to 10,100 O, Good results can be obtained.
超音波処理をする際に、植物細胞および分子に特に適当な培地は21〜28%の ショ糖を含有するCPWである。A particularly suitable medium for plant cells and molecules when sonicated is 21-28% It is a CPW containing sucrose.
本発明方法によってプラスミドDNAを導入する際に、培地中のプラスミドDN A8度を10μg/m1以上とする場合に、特に好ましい結果が得られる。When introducing plasmid DNA by the method of the present invention, plasmid DNA in the medium Particularly favorable results are obtained when the A8 degree is 10 μg/ml or more.
本発明方法の温和な超音波処理は、アキュート点(acutepoint)を有 する音波発生手段を使用し、該音波発生手段を前記培地の上側部分にのみ浸漬し て行うのが有利である。The gentle sonication of the method of the invention has an acute point. using a sound wave generating means, and immersing the sound wave generating means only in the upper part of the medium. It is advantageous to do so.
本発明方法により、テンサイ植物およびタバコ植物のような双子葉植物の植物細 胞に分子か導入されることが分った。本発明方法は単子葉植物の植物細胞に分子 を導入するのにも全く適している。By the method of the present invention, plant cells of dicotyledonous plants such as sugar beet plants and tobacco plants can be obtained. It was found that molecules were introduced into the cells. The method of the present invention applies molecules to monocot plant cells. It is also perfectly suitable for introducing.
本発明方法の他の適用性範囲は以下に示す詳細な説明から明らかである。しかし 、詳細な説明および特定の実施例は、いずれも本発明の好適例を示しているが、 例示であるにすぎず、当業者であれば、本発明の思想および範囲内における種々 の変化および変更はこの詳細な説明から明らかである。Further scope of applicability of the method according to the invention will become apparent from the detailed description given below. but Although the detailed description and specific examples indicate preferred embodiments of the invention, By way of example only, those skilled in the art will appreciate that various modifications within the spirit and scope of the invention can be made. Variations and modifications will be apparent from this detailed description.
本発明方法は、10100O0以下の期間にわたって培地中で超音波を発生する ことがてきる音波発生手段を具える装置を使用することにより、有利に実施する ことができる。このような装置は、lO〜100kHzの範囲の周波数の超音波 を発生するように設けるのか有利である。The method of the present invention generates ultrasonic waves in the culture medium for a period of 10100O0 or less. Advantageously, this can be carried out by using a device equipped with sound wave generation means that can be able to. Such a device uses ultrasonic waves at frequencies ranging from lO to 100kHz. It is advantageous to provide the system so that it occurs.
種々の仕事を行わせるために、本発明方法を実施するのに使用する装置は、音波 発生手段に供給される電力を5〜300Wの範囲の所定値に調整することかでき 、がっ超音波処理の持続期間か100〜10100O0の範囲に調整できるよう に、装着することができる。The apparatus used to carry out the method of the invention uses acoustic waves to perform various tasks. The power supplied to the generating means can be adjusted to a predetermined value in the range of 5 to 300W. , so that the duration of sonication can be adjusted to the range of 100~10100O0. It can be attached to.
この装置の音波源は、前記装置を適当な容器、例えばエッペンドルフ(Eppe ndorf )管中に浸漬できるように形成するのが有利である。音波発生手段 か細い捧の端に位置している例が、細胞物質を破壊または溶解する従来の超音波 装置から知られている。The sonic source of this device can be placed in a suitable container, such as an Eppendorf. It is advantageous to form it in such a way that it can be immersed into a tube. Sound wave generation means Conventional ultrasound, which destroys or dissolves cellular material, is an example of Known from the device.
実験から、このような従来の超音波装置を本発明方法に使用できることか分った 。本発明は細胞溶解装置を使用して開発されたもので、この装置は米国、コネチ カット州、ダンバリー、イーグルロード所在のブランラン(Branson ) 社からソニファイア−(Sonifier) B 15という商品名で商業的に 入手できる。Experiments have shown that such conventional ultrasound equipment can be used in the method of the present invention. . The present invention was developed using a cell lysis device, which is located in the United States and Branson, Eagle Road, Danbury, Cat. Commercially available from the company under the product name Sonifier B15. Available.
この装置は周波数20kHzの超音波を発生することかできる。請求の範囲を含 む本明細書中でワットて表わされている電力の値は、電源ユニットの出力制御部 から読み取られるような出力電力である。実験中、超音波発生手段を表面から測 定して約2〜3mmの位置に浸漬する。熱量計を使用した予備実験から、実験操 作中に液体に与えられる超音波の力は、与えられた出力電力の約5〜lO%であ ることか分った。他の装置を使用する場合には、当業者は後述の実施例に示すよ うにして適当な調節を決めることかでき、この調節によって温和な超音波処理お よび効果的な分子導入か行われ、十分な生存可能性か維持される。換言すれば、 この調節によって実施例の記載に従って行われた実験に相当する超音波処理の力 か生じる。比較のために、上述の装置ソニファイア−815を使用し、特記しな い限り同じ条件下に細胞を溶解するかあるいは細胞を破壊してホモジネートを生 成する際に、無傷細胞を処理する場合には、出力電力を80〜100Wに調節し 、処理期間を30000〜250000msに調節する。This device is capable of generating ultrasonic waves with a frequency of 20 kHz. including the scope of claims. The power values expressed in watts in this specification are based on the output control section of the power supply unit. is the output power as read from . During the experiment, the ultrasonic generation means were measured from the surface. 2 to 3 mm. From preliminary experiments using a calorimeter to experimental operations. The ultrasonic power applied to the liquid during operation is approximately 5-10% of the applied output power. I understand that. If other devices are used, those skilled in the art will be able to use them as shown in the examples below. The appropriate adjustment can be made by and effective molecular transfer is performed and sufficient viability is maintained. In other words, This adjustment corresponds to the sonication force in the experiments performed as described in the Examples. or occur. For comparison, the above-mentioned device Sonifier-815 was used, with no exceptions noted. Whenever possible, lyse the cells or disrupt the cells to produce a homogenate under the same conditions. When processing intact cells, adjust the output power to 80-100W. , adjust the processing period to 30000-250000ms.
上述のように、植物細胞に遺伝物質を導入するいくつかの方法か知られており、 これらの方法では前記植物細胞を先ず植物プロトプラストに変えており、前記プ ロトプラストは細胞壁という障壁を有していないので、プロトプラストに導入さ れる遺伝物質量か多くなる。他方、いくつかの植物種、特に単子葉植物のプロト プラストを全植物に再生するのは困難である。ある植物種のプロトプラストを使 用した場合に好ましい結果か得られたか、プロトプラストの代りに無傷植物細胞 、植物の胚または他の形態発生物質(morphogenous materi al)を使用するのか一層適当である他の植物種かある。実験から、本発明方法 により温和な超音波処理を使用して無傷細胞に遺伝物質を直接導入することかで き、この導入方法は複雑でない方法であり、しかも遺伝子操作に成功する植物種 の数を著しく増加することかてきるので有利であることが分った。As mentioned above, several methods are known for introducing genetic material into plant cells. In these methods, the plant cells are first transformed into plant protoplasts; Rotoplasts do not have a cell wall barrier, so they cannot be introduced into protoplasts. The amount of genetic material produced increases. On the other hand, some plant species, especially monocots, It is difficult to regenerate plastids into whole plants. using protoplasts of certain plant species. Favorable results were obtained when using intact plant cells instead of protoplasts. , a plant embryo or other morphogenetic material There are other plant species for which the use of al) is more suitable. From experiments, the method of the present invention Genetic material can be introduced directly into intact cells using milder sonication. This method of introduction is uncomplicated and can be used in plant species that can be successfully genetically engineered. This has been found to be advantageous as it allows for a significant increase in the number of
該当する遺伝物質は特にDNAまたはその断片、例えばプラスミドDNAである 。また、本発明方法は、細胞にRNAまたはその断片、ならびにウィルス、例え ば病理試験用のものを導入するのにも適している。また、本発明方法は蛋白質、 脂質、医薬組成物、小形分子、ならびにオルガネラおよびウィルス粒子を導入す るのにも適している。The relevant genetic material is in particular DNA or fragments thereof, such as plasmid DNA. . In addition, the method of the present invention can be used to inject RNA or fragments thereof into cells, as well as viruses, e.g. It is also suitable for introducing equipment for pathological tests. In addition, the method of the present invention can also be applied to proteins, Introduction of lipids, pharmaceutical compositions, small molecules, and organelles and virus particles It is also suitable for
培地としては細胞またはプロトプラスト用の従来の適当な培地を使用することが できる。The culture medium may be any suitable conventional culture medium for cells or protoplasts. can.
本発明方法は、細胞膜および細胞壁の両方を一時的に適度に弱くする技術を使用 しており、これは以下の実施例で無傷植物細胞において示されている。The method of the present invention uses technology that temporarily weakens both the cell membrane and the cell wall. This is demonstrated in intact plant cells in the Examples below.
これらの実施例はプラスミドDNAか超音波処理された植物細胞を透過できるこ とを示す。These examples demonstrate that plasmid DNA can penetrate sonicated plant cells. and
胚から得たカルスを使用して遺伝子型Ml(デンマーク国、コペンハーゲン所在 のダニスコ(DAN[SCO>社から入手できる)のテンサイ(ベータブルガリ ス、エル、(Betavulgaris L、))の細胞懸濁培養を行う準備を する。この細胞懸濁液を暗所において回転振とうテーブル上で25°Cにおいて 培養する。細胞は、5.7μMのインドール酢酸および4.4μMのベンジルア デニンを添加したMurashigeおよびSkoog (Physiol、 Plant、、 15゜473〜479.1962 )の培地において継代培養 することにより維CPWは、Frearson等(Dev、 Biol、、 3 3. 130〜137. 1973)によって記載されているように、一般的に 約10mM(7) Ca” ”を含有する無機塩混合物の水溶液である。Callus obtained from embryos was used to determine genotype Ml (Copenhagen, Denmark). Danisco (available from DAN [SCO>) sugar beet (Beta Bvlgari) Preparation for cell suspension culture of Betavulgaris L. do. This cell suspension was incubated at 25°C on a rotating shaking table in the dark. Cultivate. Cells were incubated with 5.7 μM indoleacetic acid and 4.4 μM benzyl acetate. Murashige and Skoog with addition of Denine (Physiol, Subculture in the medium of Plant, 15°473-479.1962) By doing so, the fiber CPW is based on Frearson et al. (Dev, Biol, 3 3. 130-137. As described by (1973), generally It is an aqueous solution of an inorganic salt mixture containing about 10mM (7) Ca"".
超音波処理 超音波処理に用いる細胞懸濁液は、継代培養後3〜4日目に細胞を取り出し、こ れらの細胞をCPW13S(すなわち、1396のソルビトールを含有するCP W)で2回洗浄し、最後にこれらの細胞をCPW13S中に4容量部のCPW1 3Sに対してl容量部の比で懸濁させることにより、調製する。次いで、エッペ ンドルフ管中で2193のショ糖および植物細胞(500000個/7nl)を 含有する0、 35m1のCPW中の前記懸濁液にプラスミドDNAを添加した 。使用したプラスミドDNAは標識酵素であるクロルアンフェニコール−アセチ ルトランスフェラーゼを暗号化するプラスミドで、この場合にはスエーデン国、 ウプラサ所在のファルマシアLKBバイオテクノロジー社から入手できるコード 27−4909を有するプラスミド、CaMVCMである。Ultrasonication The cell suspension used for ultrasonication is prepared by removing cells 3 to 4 days after subculturing. These cells were treated with CPW13S (i.e., CP containing 1396 sorbitol). W) and finally these cells were dissolved in 4 volumes of CPW1 in CPW13S. Prepared by suspending in a ratio of 1 part by volume to 3S. Next, Eppe 2193 sucrose and plant cells (500,000 cells/7nl) in a Lindorf tube. Plasmid DNA was added to the suspension in 0.35 ml of CPW containing . The plasmid DNA used was labeled with the labeling enzyme chloramphenicol-acetate. A plasmid encoding a transferase, in this case Sweden, Code available from Pharmacia LKB Biotechnology, Uprasa. 27-4909, CaMVCM.
ソニファイア−815(米国、コネチカット州、ダンバリー、イーグルロード所 在のブランラン社から入手できる)の微小先端部を、迅速に振とうさせた後に、 細胞懸濁液の上半部(すなわち、表面から測定して2〜3鵬の位置)に浸漬する 。周波数20kHzの超音波パルスを供給する。実験結果に示されている電力の 値は出力制画部に基づいて決める。この場合に1ユニツトは15Wの電力に相当 する。10Wの電力において、有効音響出力は0.22W / am 2である 。処理の持続期間は%で表わしたデユーティサークル(duty circle )に対する尺度(scale)によって調節し、この際に10%調節すること によって、各超音波パルスは持続期間が110msになることか保証される。1 10m5のこのようなパルスの数はオン/オフスイッチによって刺部することか できる。Sonifier-815 (Eagle Road, Danbury, CT, USA) After rapid shaking, the microtip of the Immerse in the upper half of the cell suspension (i.e. 2-3 centimeters measured from the surface) . Ultrasonic pulses with a frequency of 20 kHz are supplied. of the power shown in the experimental results. The value is determined based on the output drawing department. In this case, 1 unit corresponds to 15W of power. do. At 10W power, the effective acoustic power is 0.22W/am2 . The duration of the process is expressed as a duty circle in %. ), and adjust by 10% at this time. ensures that each ultrasound pulse has a duration of 110 ms. 1 The number of such pulses of 10m5 can be set by an on/off switch. can.
次いで、超音波で処理した細胞を、MS培地<Murash ige およびS hoog 、前記参照)の入っているペトリ皿に移し、23°Cで2日間温室す る。CAT活性の存在は、14c標識クロルアンフエニコールを処理細胞から得 た抽出物に添加し、次いでこの試料を60°Cに6分間加熱することによって示 される。冷却後に、この試料にアセチル−補酵素Aを添加して、アセチル−補酵 素Aの最終濃度を0.71mMとする。プラスミドの導入は、クロルアンフェニ コール(CA)の形質転換率(%)を測定することにより、評価した。使用した 方法は、ゴーマン(Gorman)等(Mo1. Ce1l。The ultrasonicated cells were then placed in MS medium <Murashige and S Hoog (see above) in a Petri dish and incubated in a greenhouse for 2 days at 23°C. Ru. The presence of CAT activity indicates that 14c-labeled chloramphenicol can be obtained from treated cells. of the sample and then heating the sample to 60°C for 6 minutes. be done. After cooling, acetyl-coenzyme A was added to the sample to perform acetyl-cofermentation. The final concentration of element A is 0.71 mM. Plasmid introduction is performed using chloramphenicin. The evaluation was made by measuring the transformation rate (%) of call (CA). used The method is described by Gorman et al. (Mo1.Cel.
Biol、、 2.1044〜1051.1982)の方法を改良した方法であ る。Biol., 2.1044-1051.1982). Ru.
実施例1 この実施例は遺伝子型M1の無傷テンサイ細胞へのプラスミドDNAの導入を説 明する。Example 1 This example describes the introduction of plasmid DNA into intact sugar beet cells of genotype M1. I will clarify.
テンサイ細胞の懸濁培養を上述の継代培養によって維持し、次いて上述のように して超音波処理し、培養し、分析した。CAT活性の測定結果を表1に示す。Suspension cultures of sugar beet cells were maintained by subculturing as described above and then The cells were sonicated, cultured, and analyzed. The measurement results of CAT activity are shown in Table 1.
出力 時間 形質転換したCA (ワット) (ms) (%) 000.03 60 800 0、06 75 800 0、21 90 800 0、17 105 800 0、07 実施例2 この実施例は無傷タバコ細胞へのプラスミドDNAの導入を説明する。Output time Transformed CA (Watt) (ms) (%) 000.03 60 800 0, 06 75 800 0, 21 90 800 0, 17 105 800 0, 07 Example 2 This example describes the introduction of plasmid DNA into intact tobacco cells.
タバコ細胞の懸濁培養を、テンサイ細胞懸濁液の継代培養について上述したよう に、継代培養することによって維持した。Suspension cultures of tobacco cells were grown as described above for subculture of sugar beet cell suspensions. The cells were maintained by subculturing.
ただし、培地としては、MurashigeおよびSkoog(Phsiol、 Plant、、 15.473〜497.1962 ’)の培地に0.2mg / lの2.4−ジクロロフェノキシ酢酸、0.1mg / (!のカイネチ ン、0.9mg/ (!の塩酸チアミンおよび0.2g/AのKH2PO4を添 加したpH6,0の培地を使用した。However, as a medium, Murashige and Skoog (Phsiol, Plant, 15.473-497.1962') 0.2mg / l of 2.4-dichlorophenoxyacetic acid, 0.1 mg / (! Added thiamine hydrochloride of 0.9 mg/(!) and KH2PO4 of 0.2 g/A. A medium with a pH of 6.0 was used.
細胞を継代培養後2〜3日目に取り出し、CPW13S (すなわち、1396 のソルビトールを含有するCPW)によって2回洗浄し、最後にこれらの細胞を CPW13S中に4容量部のCPW13Sに対して1容量部の比で懸濁させた。Cells were removed 2-3 days after subculturing, and CPW13S (i.e., 1396 CPW containing sorbitol) and finally these cells were washed twice with It was suspended in CPW13S at a ratio of 4 parts by volume of CPW13S to 1 part by volume.
それぞれ0.357nlの試料を取り出し、各試料にプラスミド、CaMVCN を添加し、最終プラスミド濃度を100μg/mIとした。次いで、これらの細 胞に表2に示す条件下に超音波処理を施した。上述の培地中に2日間培養した後 に、細胞を取り出し、細胞のCAT活性を測定した。測定結果を表2に示す。A sample of 0.357 nl was taken and each sample was injected with plasmid, CaMVCN. was added to give a final plasmid concentration of 100 μg/ml. Then these details The cells were subjected to ultrasonic treatment under the conditions shown in Table 2. After 2 days of culture in the medium described above. Then, the cells were taken out and the CAT activity of the cells was measured. The measurement results are shown in Table 2.
表2 出力 時間 形質転換したCA (ワット) (ms) (%) 0 0 0、05 75 570 0、06 75 800 0、13 75 1000 0、07 明らかに、本発明方法を使用して無傷植物細胞に分子を導入することができる。Table 2 Output time Transformed CA (Watt) (ms) (%) 0 0 0, 05 75 570 0, 06 75 800 0, 13 75 1000 0, 07 Clearly, the methods of the invention can be used to introduce molecules into intact plant cells.
本発明を上述のように説明したが、本発明を多様に変えることかできるのは明ら かである。このような変化は本発明の思想および精神からの逸脱と見做してはな らないことで、当業者にとって明白であるような変更はすべて本発明の範囲に包 含されるものである。Having thus described the invention, it will be obvious that the same may be modified in many ways. That's it. Such changes should not be construed as a departure from the spirit and spirit of the invention. All such modifications that are obvious to a person skilled in the art are included within the scope of the invention. included.
国際調査報告 国際調査報告 PCT/CK 90100166international search report international search report PCT/CK 90100166
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK325189A DK168302B1 (en) | 1989-06-29 | 1989-06-29 | Method of introducing molecules, especially genetic material into plant cells |
DK3251/89 | 1989-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05500304A true JPH05500304A (en) | 1993-01-28 |
Family
ID=8120791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51026590A Pending JPH05500304A (en) | 1989-06-29 | 1990-06-28 | A method of introducing molecules, especially genetic material, into plant cells |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0480971A1 (en) |
JP (1) | JPH05500304A (en) |
AU (1) | AU645260B2 (en) |
DK (1) | DK168302B1 (en) |
WO (1) | WO1991000358A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2042093C (en) * | 1990-05-09 | 2002-12-24 | Gyula Hadlaczky | Cell line carrying an excess of mammalian centromeres |
DE69628652T3 (en) | 1995-09-08 | 2012-05-03 | Genentech, Inc. | VEGF-RELATED PROTEIN |
US6030945A (en) * | 1996-01-09 | 2000-02-29 | Genentech, Inc. | Apo-2 ligand |
US6998116B1 (en) | 1996-01-09 | 2006-02-14 | Genentech, Inc. | Apo-2 ligand |
US5693512A (en) * | 1996-03-01 | 1997-12-02 | The Ohio State Research Foundation | Method for transforming plant tissue by sonication |
CA2249206A1 (en) | 1996-04-01 | 1997-10-09 | Genentech, Inc. | Apo-2li and apo-3 apoptosis polypeptides |
US6077697A (en) * | 1996-04-10 | 2000-06-20 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6025155A (en) * | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US5851984A (en) * | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US6159462A (en) * | 1996-08-16 | 2000-12-12 | Genentech, Inc. | Uses of Wnt polypeptides |
US6462176B1 (en) | 1996-09-23 | 2002-10-08 | Genentech, Inc. | Apo-3 polypeptide |
US5990281A (en) * | 1996-09-30 | 1999-11-23 | Genentech, Inc. | Vertebrate smoothened proteins |
WO1998058062A1 (en) | 1997-06-18 | 1998-12-23 | Genentech, Inc. | Apo-2DcR |
US6342369B1 (en) | 1997-05-15 | 2002-01-29 | Genentech, Inc. | Apo-2-receptor |
JP2001523977A (en) | 1997-06-05 | 2001-11-27 | ザ ユニバーシティ オブ テキサス システム ボード オブ リージェンツ | Activator of APAF-1, CED-4 human homolog, caspase-3 |
US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
ATE411385T1 (en) | 1998-01-15 | 2008-10-15 | Genentech Inc | APO-2 LIGAND |
US6114603A (en) * | 1998-03-27 | 2000-09-05 | John Innes Center | Genetic engineering of sugarbeet plants |
DE19834612A1 (en) * | 1998-07-31 | 2000-02-24 | Dornier Medtech Holding Int Gmbh | Method for intracellular transfer of oligonucleotides and device for carrying out the same |
US6195936B1 (en) * | 1999-02-22 | 2001-03-06 | University Of Iowa Research Foundation | Method for uptake of a substance into a seed |
CN101633692A (en) | 1999-06-28 | 2010-01-27 | 杰南技术公司 | Methods for making apo-2 ligand using divalent metal ions |
DE19962904A1 (en) * | 1999-12-23 | 2001-08-09 | Dornier Medizintechnik | Apparatus continuously introducing molecules into cells, avoiding their total disruption, focuses controlled acoustic pulses at axis of duct passing carrier fluid |
JP5062606B2 (en) | 2000-02-16 | 2012-10-31 | ジェネンテック, インコーポレイテッド | Use of agonists and antagonists to modulate the activity of TNF-related molecules |
CA2448096A1 (en) | 2001-05-30 | 2002-12-05 | Chromos Molecular Systems, Inc. | Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
KR100942880B1 (en) | 2001-08-29 | 2010-02-17 | 제넨테크, 인크. | Bv8 Nucleic Acids and Polypeptides with Mitogenic Activity |
US20040186051A1 (en) | 2001-10-02 | 2004-09-23 | Kelley Robert F | Apo-2 ligand variants and uses thereof |
CA2466054C (en) | 2001-11-13 | 2012-01-03 | Genentech, Inc. | Apo-2 ligand/trail formulations |
DE10223196B4 (en) | 2002-05-24 | 2004-05-13 | Dornier Medtech Systems Gmbh | Method and device for transferring molecules into cells |
JP4574350B2 (en) | 2002-06-24 | 2010-11-04 | ジェネンテック, インコーポレイテッド | APO-2 ligand / TRAIL variant and methods of use thereof |
EP2526960A1 (en) | 2003-03-12 | 2012-11-28 | Genentech, Inc. | Use of BV8 and/or EG-VEGF to promote hematopoiesis |
PT1631313E (en) | 2003-06-05 | 2015-07-02 | Genentech Inc | Combination therapy for b cell disorders |
DE602005019367D1 (en) | 2004-12-15 | 2010-04-01 | Dornier Medtech Systems Gmbh | Enhanced cell therapy and tissue regeneration via shock waves in patients with cardiovascular and neurological diseases |
GB2452543B (en) * | 2007-09-07 | 2012-07-25 | Wei Huang | Nucleic acid transfer techniques |
DK2233149T3 (en) | 2007-10-16 | 2016-05-17 | Zymogenetics Inc | COMBINATION OF TRANSMEMBRANAKTIVATOR AND CALCIUM MODULATOR AND cyclophilin-LIGAND INTERAKTOR (TACI) AND ANTI-CD20 MEANS FOR TREATMENT OF AUTO-IMMUNE DISEASE |
US8669085B2 (en) | 2009-02-05 | 2014-03-11 | Ut-Battelle, Llc | Transformation of gram positive bacteria by sonoporation |
BR112012002974B1 (en) | 2009-08-11 | 2022-06-07 | Genentech, Inc | Process for producing an antibody in a Chinese hamster ovary (cho) cell host cell expressing said polypeptide |
CA2834776A1 (en) | 2011-05-03 | 2012-11-08 | Genentech, Inc. | Therapeutic apo2l/trail polypeptides and death receptor agonist antibodies |
KR101791563B1 (en) * | 2015-05-11 | 2017-11-02 | 대한민국 | Method for delaying the ripening of fruits using sound treatment |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3537261A1 (en) * | 1985-10-19 | 1987-04-30 | Gca Corp | METHOD AND MEDIUM FOR FIELD-INDUCED INSERTING MACROMOLECULES IN LIVING CELLS |
HUT46741A (en) * | 1987-05-05 | 1988-11-28 | Sandoz Ag | Process for transformation of plant-cells |
GB8721015D0 (en) * | 1987-09-07 | 1987-10-14 | Amersham Int Plc | Modifying living cells |
-
1989
- 1989-06-29 DK DK325189A patent/DK168302B1/en not_active IP Right Cessation
-
1990
- 1990-06-28 EP EP19900910596 patent/EP0480971A1/en not_active Ceased
- 1990-06-28 JP JP51026590A patent/JPH05500304A/en active Pending
- 1990-06-28 AU AU60432/90A patent/AU645260B2/en not_active Expired - Fee Related
- 1990-06-28 WO PCT/DK1990/000166 patent/WO1991000358A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1991000358A1 (en) | 1991-01-10 |
DK325189A (en) | 1990-12-30 |
DK325189D0 (en) | 1989-06-29 |
DK168302B1 (en) | 1994-03-07 |
AU645260B2 (en) | 1994-01-13 |
EP0480971A1 (en) | 1992-04-22 |
AU6043290A (en) | 1991-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05500304A (en) | A method of introducing molecules, especially genetic material, into plant cells | |
JP2739978B2 (en) | Method and apparatus for cell poration and cell fusion by high frequency electrical pulses | |
WO2018071663A1 (en) | Rna compositions for genome editing | |
Murphy et al. | Isolation and Characterization of Spermidine Nucleoids fromEscherichia coli | |
WO2016014794A1 (en) | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells | |
JP6861803B2 (en) | High-efficiency transfection of biological cells using sonoporation | |
Kilby et al. | Repeated harvest of vacuole-located secondary product from in vitro grown plant cells using 1.02 MHz ultrasound | |
Morales et al. | Light‐Triggered Genome Editing: Cre Recombinase Mediated Gene Editing with Near‐Infrared Light | |
JPH02501264A (en) | Modification of viable cells | |
Anderson et al. | Electroporation of lymphoid cells: factors affecting the efficiency of transfection | |
JPWO2019069931A1 (en) | Cell culture vessel, cell acquisition method, and cell culture method | |
JPH03502044A (en) | Cell generation method | |
Kavipriya et al. | Genetic transformation methods for crop improvement: a brief review | |
KR20020029126A (en) | Device for introducing pores into biological materials | |
US6503755B1 (en) | Particle transfection: rapid and efficient transfer of polynucleotide molecules into cells | |
CN106755093A (en) | The technique that drosophila cell is transiently transfected | |
RU2663347C1 (en) | Method of delivering biologically active macromolecules into the cells of plants | |
JP4022614B2 (en) | New biobead manufacturing method | |
JP6449057B2 (en) | Method of substance introduction into cells using nanoneedle array | |
Fisk et al. | Electroporation: introduction and expression of transgenes in plant protoplasts | |
EP2997125B1 (en) | Method and device for cell lysis or poration | |
Terzaghi et al. | Plant cell transfection by electroporation | |
US20020081737A1 (en) | Novel method for introduction of an exogenous genetic substance or a physiologically active compound | |
Rakotondrafara et al. | Preparation and electroporation of oat protoplasts from cell suspension culture | |
JPWO2020075399A1 (en) | Method of introducing protein into the nucleus of plant cells |